维普期刊资源整合服务平台（V6.5）

241篇 您的检索式：作者名="PAESMANS M"

选中清除导出查看参考文献查看引证文献引用追踪共13页首页上一页第1页下一页末页 /13 跳转

	题名	作者	年代	出处	被引量
1	The role of HER-2/neu expression on the survival of patients with lung cancer:a systematic review of the literature显示文摘	Meert AP Martin B Paesmans M	2003	Br J Cancer2003，89，6：	1
2	Survival improvement in resectable non - small cell lung cancer with ( neo ) adjuvant chemotherapy:results of a meta - analysis of the literature 显示文摘	Berghmans T Paesmans M Meert AP	2005	Lung Cancer2005，49，1：	1
3	A prospective study on hyponatraemia in medical cancer patients :epidemiology, aetiology and differential diagnosis 显示文摘	Berghmans T Paesmans M Body J J	2000	Support Care Cancer2000，8，3：	1
4	Ki67 expression and patients survival in lug cancer: systematic review of the literature with meta-analysis显示文摘	Martin B Paesmans M Mascaux C	2004	BrJ Cancer2004，91，12：	1
5	Role of Bcl-2 as a prog nostic factor for survival in lung cancer : A systematic review of the literature with meta-analysis显示文摘	Martin B Paesmans M Berghmans T	2003	Br J Cancer2003，89，：	1
6	The role of HER-2/neu expression on the survival of patients with lung cancer:a systematic review of the literature显示文摘	Meert AP Martin B Paesmans M	2003	Br J Cancer2003，89，6：	1
7	Correlation between topoisomerase-Ⅱ alpha gene amplification and protein expression in HER-2 amplified breast cancer显示文摘	Durbecq V Desmed C Paesmans M	2004	Int J Oncol2004，25，5：	1
8	Topoisomerase-II alpha expression as a predictive marker in a populationof advanced breast cancer patients randomly treated eitherwith single-agent doxorubicin or single-agent docetaxel显示文摘	Durbecq V Paesmans M Cardoso F	2004	Mol Cancer Ther2004，3，10：	1
9	A comparison of methods of calculation for estimating carboplatin AUC with a retrospective pharmacokinetic-pharmacodynamic analysis in patients with advanced non-small cell lung cancer显示文摘	Sculier JP Paesmans M Thiriaux J	1999	Eur J Cancer1999，35，9：	1
10	Activity of chemo-therapy and immunotherapy on malignant mesothelioma: a sys-tematic review of the literature with meta-analysis 显示文摘	Berghmans T Paesmans M Lalami Y	2002	LungCancer2002，38，2：	1
11	The Multinational Association for Supportive Care in Cancer (MASCC) risk index score: 10 years of use for identifying low-risk febrile neutropenic cancer patients 显示文摘	Klastersky J Paesmans M	2013	Surport Care Caneer2013，21，5：	1
12	A prospective study on hyponatraemia in medical cancer patients:epidemiology, aetiology and differential dignosis显示文摘	Berghmans T Paesmans M Body JJ	2000	Support Care Cancer2000，8，3：	1
13	Expression of thrombospondin in non-small cell lung cancer显示文摘	Mascaux C Martin B Paesmans M	2002	Anticancer Res2002，22，2：	1
14	Imipenem versus targetedtherapyin cancer patients显示文摘	Aoun M Crokaert F Paesmans M	1998	Int J Antimicrob Agents1998，10，4：	1
15	Role of Bcl-2 as a prognostic factor for survival in lung cancer:a systematic review of the literature with meta-analysis显示文摘	Martin B Paesmans M Berghmans T	2003	BrJ Cancer2003，89，1：	1
16	Prognostic factors in stage III non-small cell lung cancer : a review of conventional, metabolic and new biological variables 显示文摘	Berghmans T Paesmans M Sculier JP	2011	Therapeutic Advances in Medical Oncology2011，3，3：	1
17	Prognostic factors for patients with small cell lung carcinoma:analysis of a serics of 763 patients included in 4 consecutive prospective trials with a minimum follow-up of 5 years显示文摘	Paesmans M Sculier JP Lecomte J		0，，：	1
18	Survival improvement in resectable non-small cell lung cancer with (neo) adjuvant chemotherapy:results of a meta-analysis of the literature显示文摘	Berghmans T Paesmans M Meert AP	2005	Lung Cancer2005，49，1：	1
19	Imipenem versus targeted therapy in cancer patients显示文摘	Aoun M Crokaert F Paesmans M	1998	Int J Antimicrob Agents1998，10，4：	1
20	Survival improvement in resectable non-small cell lung cancer with(neo)adjuvant chemotherapy:results of a meta-analysis of the literature显示文摘	BERGHMANS T PAESMANS M MEERT A P	2005	Lung Cancer2005，49，1：	1

返回顶部每页显示：

共13页首页上一页第1页下一页末页 /13 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示